A Path to Real-World Evidence in Critical Care Using Open-Source Data Harmonization Tools

Author:

Heavner Smith F.12,Anderson Wesley3,Kashyap Rahul45,Dasher Pamela1,Mathé Ewy A.6,Merson Laura7,Guerin Philippe J.89,Weaver Jeff10,Robinson Matthew11,Schito Marco1,Kumar Vishakha K.12,Nagy Paul13

Affiliation:

1. CURE Drug Repurposing Collaboratory, Critical Path Institute, Tucson, AZ.

2. Department of Public Health Sciences, Clemson University, Clemson, SC.

3. Quantitative Medicine, Critical Path Institute, Tucson, AZ.

4. Department of Research, WellSpan Health, York, PA.

5. Department of Anesthesia and Critical Care Medicine, Mayo Clinic, Rochester, MN.

6. Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD.

7. ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, United Kingdom.

8. Infectious Diseases Data Observatory, University of Oxford, Oxford, United Kingdom.

9. Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.

10. Office of Information Technology, Emory University, Atlanta, GA.

11. Department of Medicine–Infectious Disease, Johns Hopkins University, Baltimore, MD.

12. Society for Critical Care Medicine, Mount Prospect, IL.

13. Johns Hopkins University School of Medicine, Baltimore, MD.

Abstract

COVID-19 highlighted the need for use of real-world data (RWD) in critical care as a near real-time resource for clinical, research, and policy efforts. Analysis of RWD is gaining momentum and can generate important evidence for policy makers and regulators. Extracting high quality RWD from electronic health records (EHRs) requires sophisticated infrastructure and dedicated resources. We sought to customize freely available public tools, supporting all phases of data harmonization, from data quality assessments to de-identification procedures, and generation of robust, data science ready RWD from EHRs. These data are made available to clinicians and researchers through CURE ID, a free platform which facilitates access to case reports of challenging clinical cases and repurposed treatments hosted by the National Center for Advancing Translational Sciences/National Institutes of Health in partnership with the Food and Drug Administration. This commentary describes the partnership, rationale, process, use case, impact in critical care, and future directions for this collaborative effort.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3